Publication:
Diffuse alveolar hemorrhage following intravenous thrombolytic treatment in acute ischemic stroke: a case series

dc.contributor.authorMİDİ, İPEK
dc.contributor.authorsAtmaca, Murat Mert; Simsek, Ugur Burak; Midi, Ipek; Aliev, Rustem; Aytac, Emrah; Kocaturk, Mehtap
dc.date.accessioned2022-03-12T22:44:24Z
dc.date.accessioned2026-01-10T18:35:22Z
dc.date.available2022-03-12T22:44:24Z
dc.date.issued2020
dc.description.abstractDiffuse alveolar hemorrhage (DAH) following fibrinolytic therapy is a rare but a life-threatening complication. In acute ischemic stroke (AIS), DAH as a complication was not reported following intravenous thrombolytic therapy (ITT). The demographic, clinical, radiologic, and prognostic data of 4 patients with AIS who developed DAH after ITT are presented in this case series, along with a literature review.
dc.identifier.doi10.1007/s10072-019-03997-y
dc.identifier.eissn1590-3478
dc.identifier.issn1590-1874
dc.identifier.pubmed31280387
dc.identifier.urihttps://hdl.handle.net/11424/236426
dc.identifier.wosWOS:000511744100035
dc.language.isoeng
dc.publisherSPRINGER-VERLAG ITALIA SRL
dc.relation.ispartofNEUROLOGICAL SCIENCES
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectDiffuse alveolar hemorrhage
dc.subjectIntravenous thrombolytic treatment
dc.subjectAcute ischemic stroke
dc.subjectPrognosis
dc.subjectTHERAPY
dc.titleDiffuse alveolar hemorrhage following intravenous thrombolytic treatment in acute ischemic stroke: a case series
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage237
oaire.citation.issue1
oaire.citation.startPage233
oaire.citation.titleNEUROLOGICAL SCIENCES
oaire.citation.volume41

Files